Status
Conditions
Treatments
About
This multi-site study is being conducted to examine dietary and activity patterns, body composition, blood and quality of life in breast cancer patients. The study will recruit 176 women with MBC in Milwaukee (n=88) and Chicago (n=88).
Full description
Aims/Objectives
Aim 1. To examine the efficacy of the Every Day Counts intervention in producing significant post-intervention changes in multidimensional QOL in women with MBC.
Hypothesis 1: Women randomized to the immediate EDC intervention (n=88) will exhibit greater improvements in multidimensional QOL compared to women randomized to the attention control (n=88).
Aim 2. To investigate the mechanistic effects of the Every Day Counts intervention on body composition, adipokines, serum biomarkers of inflammation and insulin sensitivity.
Hypothesis 2: The EDC intervention leads to improved QOL through mediating factors including body composition, prognostic serum biomarkers of inflammation and/or insulin resistance.
Exploratory Aim 3: To explore if microRNA (miRNA) signatures associated with inflammation and/or Metabolomics are altered with the EDC intervention.
Hypothesis: miRNAs identified in our pilot study (miR-10a-5p, miR-205-5p, and miR-211-5p) that regulate inflammation and/or Metabolomics will be related to QOL improvements and can identify women more likely to respond to lifestyle changes.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Adult (≥ 18 years), female
Confirmed Metastatic Breast Cancer
Patients clinically stable with treated brain metastases are eligible
Written documentation from their oncologist permitting study participation
Determined to be "clinically stable" by their medical oncologist (i.e., no unintentional weight loss, no new symptoms or change in performance status for the past 4 weeks, no clinical [including laboratory] or radiologic evidence of disease progression, no recent or planned change in anti-neoplastic therapies, no reports of severe pain [≥ Grade 3 per the NCI CTCAE)
Life expectancy >6 months
-Written documentation from their oncologist permitting study participation
Access to a mobile phone
Understand/speak English fluently.
Non-adherence to ACS nutritional or PA guidelines for cancer survivors as documented by questionnaire.
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
176 participants in 2 patient groups
Loading...
Central trial contact
Kathleen OConnell, MSW
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal